Cytomegalovirus (CMV) contributes to increased morbidity and mortality after transplantation. Unwanted side effects of antiviral and immunosuppression further complicate treatment and recovery. In this activity, learners will explore evidence-based prevention and treatment strategies that optimize the safety and efficacy of antivirals to improve patient outcomes.
Upon completion of this activity, participants should be better able to:
Professor and Chair
G. P. Bodey, Sr. Distinguished Professorship, Infectious Diseases
Director, Clinical Virology Research
Department of Infectious Diseases, Infection Control, and Employee Health
The University of Texas MD Anderson Cancer Center
Houston, TX
Professor, Department of Medicine
University of Toronto
R. Fraser Elliott Chair, Transplantation
University Health Network
Director, University of Toronto Transplant Institute
Toronto, ON, Canada
Partners for Advancing Clinical Education (Partners) requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Partners policies. Others involved in the planning of this activity have no relevant financial relationships.
Roy F. Chemaly, MD, MPH, FACP, FIDSA, FESCMID, has relevant financial relationship(s) with ADMA Biologics, Aicuris, Ansun Pharmaceuticals, Assembly Bio, Astellas, Gilead, IntegerBio, Karius, Merck, Moderna, Oxford Immunotec, Pfizer, Pulmotec, Roche/Genentech, Shionogi, Takeda, Tether, Viracor-Eurofins (Consultant); Aicuris, Ansun Biopharmaceuticals, Genentech, Karius, Merck, OM1, Oxford Immunotec, Takeda, Viracor-Eurofins (Researcher).
Atul Humar, MD, FRCPC, FAST, has relevant financial relationship(s) with Takeda (Consultant); Biotest, Kamada, Takeda, Viracor-Eurofins (Speaker); Synklino (Research Support).
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners) and RMEI Medical Education, LLC. Partners is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Partners designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Pharmacy Education
Partners designates this continuing education activity for 1.0 contact hour(s) (0.10 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number – JA4008073-9999-26-093-H01-P
Type of Activity: Knowledge
Participation in this self-study activity should be completed in approximately 1.0 hour(s). To successfully complete this activity and receive CE credit, learners must follow these steps:
Users must:
You must receive a test score of at least 75% and respond to all evaluation questions to receive a certificate.
For Pharmacists: Upon successfully completing the post-test with a score of 75% or better and the online evaluation, your credit will be submitted to CPE Monitor. Please check your NABP account within thirty (30) days to make sure the credit has posted.
Your Feedback is Important!
As a sign of gratitude for providing vital outcomes data used for the development of future educational programming, you will be entered into a drawing for a $100 Amazon gift card!*
*The expense for this gift card is solely funded by RMEI Medical Education, LLC.
No supporter funding was used for the expense of this gift card.
This incentive is managed by the joint providers, Partners for Advancing Clinical Education (Partners) and RMEI Medical Education, LLC (RMEI). For participants who meet eligibility criteria (ie, completion of the evaluation form and providing contact information), RMEI will select the winner(s) via automated random drawing on a quarterly basis from among all eligible entries and will be notified through the contact information provided. Open to those who have a US postal address and who are 18 years or older. Only one prize per person and per household will be awarded. The prize will be a $100 Amazon gift card.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Featured RMEI CE Activities
Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources
